Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 5:24 pm Purchase |
2024-12-31 | 13G | Voyager Therapeutics, Inc. VYGR |
Armistice Capital, LLC | 5,396,000 9.880% |
196,000 (+3.77%) |
Filing History |
| 2024-11-14 6:13 pm Purchase |
2024-09-30 | 13G | Voyager Therapeutics, Inc. VYGR |
EcoR1 Capital LLC | 5,617,719 9.990% |
1,766,212 (+45.86%) |
Filing History |
| 2024-11-14 5:12 pm Purchase |
2024-09-30 | 13G | Voyager Therapeutics, Inc. VYGR |
Armistice Capital, LLC | 5,200,000 9.540% |
964,000 (+22.76%) |
Filing History |
| 2024-08-07 4:10 pm Purchase |
2024-07-31 | 13G | Voyager Therapeutics, Inc. VYGR |
BLACKROCK INC BLK |
5,459,941 10.000% |
2,827,262 (+107.39%) |
Filing History |
| 2024-02-14 4:19 pm Sale |
2023-12-31 | 13G | Voyager Therapeutics, Inc. VYGR |
Third Rock Ventures III L.P. | 186,423 0.400% |
-5,279,211 (-96.59%) |
Filing History |
| 2024-02-14 2:35 pm Purchase |
2023-12-31 | 13G | Voyager Therapeutics, Inc. VYGR |
Armistice Capital, LLC | 4,236,000 9.630% |
840,000 (+24.73%) |
Filing History |
| 2024-02-13 5:17 pm Purchase |
2023-12-29 | 13G | Voyager Therapeutics, Inc. VYGR |
The Vanguard Group | 2,529,668 5.750% |
574,496 (+29.38%) |
Filing History |
| 2024-01-29 5:25 pm Purchase |
2023-12-31 | 13G | Voyager Therapeutics, Inc. VYGR |
BLACKROCK INC BLK |
2,632,679 6.000% |
1,690,013 (+179.28%) |
Filing History |
| 2023-02-24 06:15 am Purchase |
2023-02-23 | 13D | Voyager Therapeutics, Inc. VYGR |
NEUROCRINE BIOSCIENCES INC NBIX |
8,575,316 19.900% |
4,395,588 (+105.16%) |
Filing History |
| 2023-02-14 4:02 pm Sale |
2022-12-31 | 13G | Voyager Therapeutics, Inc. VYGR |
Third Rock Ventures III L.P. | 5,465,634 14.200% |
-3,953,663 (-41.97%) |
Filing History |
| 2023-02-14 1:44 pm Purchase |
2022-12-31 | 13G | Voyager Therapeutics, Inc. VYGR |
Armistice Capital, LLC | 3,396,000 8.800% |
3,396,000 (New Position) |
Filing History |
| 2023-02-09 11:37 am Sale |
2022-12-30 | 13G | Voyager Therapeutics, Inc. VYGR |
The Vanguard Group | 1,955,172 5.060% |
-116,873 (-5.64%) |
Filing History |
| 2023-01-13 4:33 pm Sale |
2023-01-11 | 13G | Voyager Therapeutics, Inc. VYGR |
EcoR1 Capital LLC | 3,851,507 9.980% |
-425,000 (-9.94%) |
Filing History |
| 2022-04-26 12:58 pm Purchase |
2022-04-21 | 13G | Voyager Therapeutics, Inc. VYGR |
EcoR1 Capital LLC | 4,276,507 11.100% |
719,000 (+20.21%) |
Filing History |
| 2022-02-14 9:54 pm Sale |
2021-12-31 | 13G | Voyager Therapeutics, Inc. VYGR |
Armistice Capital, LLC | 0 0.000% |
-3,392,000 (Position Closed) |
Filing History |
| 2022-02-14 4:01 pm Unchanged |
2021-12-31 | 13G | Voyager Therapeutics, Inc. VYGR |
EcoR1 Capital LLC | 3,557,507 9.400% |
0 (Unchanged) |
Filing History |
| 2022-02-11 4:34 pm Sale |
2021-12-31 | 13G | Voyager Therapeutics, Inc. VYGR |
BB BIOTECH AG | 0 0.000% |
-2,680,283 (Position Closed) |
Filing History |
| 2022-02-10 08:42 am Sale |
2021-12-31 | 13G | Voyager Therapeutics, Inc. VYGR |
The Vanguard Group | 2,072,045 5.460% |
-345,606 (-14.30%) |
Filing History |
| 2021-10-22 4:46 pm Purchase |
2021-10-12 | 13G | Voyager Therapeutics, Inc. VYGR |
EcoR1 Capital LLC | 3,557,507 9.400% |
3,557,507 (New Position) |
Filing History |
| 2021-07-12 08:29 am Sale |
2021-06-30 | 13G | Voyager Therapeutics, Inc. VYGR |
BLACKROCK INC BLK |
942,666 2.500% |
-1,587,065 (-62.74%) |
Filing History |